Last quarter (Q2 2024), Lexeo Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q2, Lexeo Therapeutics, Inc.'s net income was $-21.24M. See Lexeo Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22
Total Revenue
$ 654.00K
Cost of Revenue
-
Gross Profit
$ 654.00K
Operating Expense
$ 61.16M
Operating Income
$ -60.51M
Net Non Operating Interest Income Expense
$ 1.23M
Other Income Expense
$ 2.00K
Pretax Income
$ -59.28M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -59.28M
Basic EPS
$ -36.36
Diluted EPS
$ -36.36
Basic Average Shares
$ 1.63M
Diluted Average Shares
$ 1.63M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 61.16M
Net Income From Continuing And Discontinued Operation
$ -59.28M
Normalized Income
-
Interest Expense
-
EBIT
-
EBITDA
-
Currency in USD
Lexeo Therapeutics, Inc. Earnings and Revenue History